Extract Asthma diagnosis in children aged 5 years and older remains a persistent clinical challenge. International guidelines from the European Respiratory Society (ERS) and the Global Initiative for Asthma (GINA) provide structured diagnostic algorithms that emphasise objective testing, including spirometry and bronchodilator reversibility, and biomarkers such as fractional exhaled nitric oxide (FENO) 1, 2. However, the implementation of these recommendations is highly dependent on local healthcare resources and infrastructure.
Lex et al. (Fri,) studied this question.